Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Antibody treatments show promise for hair loss but need more research.